2nd Quarter - Report
THE DUBERSTEIN GROUP INC. for PHRMA INC.
Client
Income
$75,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug pricing Issues related to drug manufacturing Issues related to the Food and Drug Amendments Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| BENJAMIN R HOWARD | — |
| KATHERINE WINKLER KEATING | — |
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.